Header cover image
  • Investing Ideas
  • /
  • Australian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

Australian Pharmaceuticals & Biotech Net Cash Stocks With A Growth Track Record

Results

2

0 new

These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.

2 companies

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$18.89

7D

1.2%

1Y

20.9%

Cryosite

Market Cap: AU$58.6m

Provides outsourced clinical trials logistic services in Australia.

CTE

AU$1.20

7D

0%

1Y

36.4%